Other News To Note
• Bergenbio AS, of Bergen, Norway, published a paper in Blood identifying a significant role for the Axl receptor in progression and therapeutic resistance of acute myelogenous leukemia (AML).
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.